Clinical Trial Update: Topical MTS-01 for Dermatitis During Radiation and Chemotherapy for Anal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial update for Topical MTS-01 in dermatitis during radiation and chemotherapy for anal cancer; the study is terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Drugs mentioned

• Topical MTS-01

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Anal Cancer | Phase 1 | Status: TERMINATED | Results posted: 2021-11-23